Document Detail


Variability of steady-state digoxin kinetics during administration of tablets or capsules.
MedLine Citation:
PMID:  3948469     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An encapsulated solution of digoxin has been repeatedly shown to have greater bioavailability than tablet forms of the drug. It is predicted that such a preparation would show reduced within- and between-patient variability in absorption, as most studies in normal subjects have shown reduced intersubject variation with the capsule. We tested inter- and intrapatient variability during 4-week periods of dosing with digoxin capsules and tablets in 28 subjects with cardiac disease. In the overall group there were no significant differences between the formulations at steady state in between-patient variability in trough serum digoxin concentrations or 24-hour urinary digoxin excretion. Within-patient variability in urinary digoxin excretion was somewhat lower for the capsules. In a subgroup of six patients who excreted significant amounts of cardioinactive bacterial metabolites (digoxin reduction products [DRP]), the mean (+/- SD) percent urinary DRP excretion was less (p less than 0.05) during capsule (20.5% +/- 15.1%) than tablet (34.4% +/- 10.9%) dosing. Within-patient variability in urinary DRP excretion was much greater after tablets than capsules. Certain subgroups of patients should benefit from the enhanced bioavailability of digoxin capsule preparations.
Authors:
B F Johnson; J Lindenbaum; E Budnitz; R Marwaha
Related Documents :
7285319 - [14c]oxalate absorption by normal persons, calcium oxalate stone formers, and patients ...
2351929 - A prospective study of the diagnostic value of urinary thromboxane in patients presenti...
6326759 - Aberrant porphyrin metabolism in hepatocellular carcinoma.
8162449 - Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in ...
21384289 - Cerebral abnormalities in infants with myelomeningocele.
1519229 - Pharmacology of r-hirudin in renal impairment.
19458429 - Inter-rater reliability of the modified modified ashworth scale as a clinical tool in m...
12064849 - Linear growth and final height in patients with systemic juvenile idiopathic arthritis ...
6882039 - Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  39     ISSN:  0009-9236     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  1986 Mar 
Date Detail:
Created Date:  1986-04-10     Completed Date:  1986-04-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  306-12     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorption
Adult
Aged
Atrial Fibrillation / drug therapy
Biological Availability
Blood
Capsules
Digoxin / administration & dosage,  blood,  metabolism*,  therapeutic use
Evaluation Studies as Topic
Female
Heart Failure / drug therapy
Humans
Male
Middle Aged
Radioimmunoassay
Tablets
Grant Support
ID/Acronym/Agency:
HL 10608/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Capsules; 0/Tablets; 20830-75-5/Digoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of age on ranitidine pharmacokinetics.
Next Document:  Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administra...